Actually, that’s correct / to be clearer I shoul
Post# of 11802
(Total Views: 368)
Posted On: 04/23/2020 6:47:40 AM
Re: thevibeguy #9929
Actually, that’s correct / to be clearer I should say “the Flu vaccine platform is not expected to have any use against CV.”
We don’t know what degree genetics and/or environment play their respective roles with CV, yet.
SARS1 and MERS were orders of magnitude more leathal.. it’s a combination of a lot of factors:
- no previous immunity
- longest asymptomatic transmission phase of any known (primarily) respiratory pathogen
- high infectivity
- available ICU units / staff / ventilation
The problem is, if everyone gets it at once, then people who could, under less stressful conditions, be saved will more likely perish. Couple the toll it is taking on physicians and healthcare professionals, and it’s much better to have any epidemic happen after they’ve recovered, hopefully have some immunity (though that’s unclear), and after some better treatment regimens have been tested and confirmed. We don’t understand what exactly we’re up against, and this time is critical to mount an effective response.
HCQ has been show to increase mortality in severe to critical CV/ARDS patients. HCQ’s MOA does not improve that.
Some are trying to politicize this, they should be ignored. Nothing they say or do will have any bearing on the outcome or the election.
What is happening now is the world is scrambling to contain the pandemic, once that is not the primary concern, attention will turn towards where the virus originated, how it was introduced (not bat soup), and what actions were taken, after realizing it couldn’t be contained, to spread it.
One of the GenViro products could be useful; I don’t think it will be complete in time to have much impact on CV. The other? For the sake of humanity, it would be great if it was what was needed, when it was needed. Maybe today that will be established... maybe today, it will be another “plane leaving the tarmac” moment. Nobody can be sure until afterwards.
We don’t know what degree genetics and/or environment play their respective roles with CV, yet.
SARS1 and MERS were orders of magnitude more leathal.. it’s a combination of a lot of factors:
- no previous immunity
- longest asymptomatic transmission phase of any known (primarily) respiratory pathogen
- high infectivity
- available ICU units / staff / ventilation
The problem is, if everyone gets it at once, then people who could, under less stressful conditions, be saved will more likely perish. Couple the toll it is taking on physicians and healthcare professionals, and it’s much better to have any epidemic happen after they’ve recovered, hopefully have some immunity (though that’s unclear), and after some better treatment regimens have been tested and confirmed. We don’t understand what exactly we’re up against, and this time is critical to mount an effective response.
HCQ has been show to increase mortality in severe to critical CV/ARDS patients. HCQ’s MOA does not improve that.
Some are trying to politicize this, they should be ignored. Nothing they say or do will have any bearing on the outcome or the election.
What is happening now is the world is scrambling to contain the pandemic, once that is not the primary concern, attention will turn towards where the virus originated, how it was introduced (not bat soup), and what actions were taken, after realizing it couldn’t be contained, to spread it.
One of the GenViro products could be useful; I don’t think it will be complete in time to have much impact on CV. The other? For the sake of humanity, it would be great if it was what was needed, when it was needed. Maybe today that will be established... maybe today, it will be another “plane leaving the tarmac” moment. Nobody can be sure until afterwards.
(0)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼